Ikena Oncology Inc

NASDAQ:IKNA   4:00:00 PM EDT
2.22
-0.01 (-0.45%)
4:00:16 PM EDT: $2.22 0.00 (0.00%)
Earnings Announcements

Ikena Oncology Reports Third Quarter Results

Published: 11/07/2022 14:34 GMT
Ikena Oncology Inc (IKNA) - Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update.
Next Development Candidate in Ras Pathway to Be Announced by Year End 2022.
Qtrly Loss per Share $0.48.
Q3 Earnings per Share View $-0.50 -- Refinitiv Ibes Data (analyst estimates).
As of September 30, 2022, Ikena Had $174.4 Million in Cash, Cash Equivalents, and Marketable Securities.
Believes Cash, Cash Equivalents, and Marketable Securities to Be Sufficient to Meet Its Operating Requirements Through Mid-2024.
Revenue is expected to be $19.96 Million
Adjusted EPS is expected to be -$0.15

Next Quarter Revenue Guidance is expected to be $4.05 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.